Zhejiang Garden Bio-chemical High-tech Co Ltd
Zhejiang Garden Biopharmaceutical Co.,Ltd. operates as a food additive and pharmaceutical manufacturing industry in China. The company provides lanolin cholesterol, vitamin A and AD3 particles, vitamin D3, 25-hydroxyvitamin D3, chemical drugs and Chinese patent medicines. It offers cholesterol; feed grade vitamin D3, refined lanolin; food additives compound nutrient fortifier SDS, CO, and MO; cho… Read more
Market Cap & Net Worth: Zhejiang Garden Bio-chemical High-tech Co Ltd (300401)
Zhejiang Garden Bio-chemical High-tech Co Ltd (SHE:300401) has a market capitalization of $1.12 Billion (CN¥8.19 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #8548 globally and #1638 in its home market, demonstrating a -2.08% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Garden Bio-chemical High-tech Co Ltd's stock price CN¥15.07 by its total outstanding shares 543469905 (543.47 Million).
Zhejiang Garden Bio-chemical High-tech Co Ltd Market Cap History: 2015 to 2026
Zhejiang Garden Bio-chemical High-tech Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $802.88 Million to $1.12 Billion (7.07% CAGR).
Zhejiang Garden Bio-chemical High-tech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Garden Bio-chemical High-tech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.87x
Zhejiang Garden Bio-chemical High-tech Co Ltd's market cap is 0.87 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
3.51x
Zhejiang Garden Bio-chemical High-tech Co Ltd's market cap is 3.51 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $802.88 Million | $151.22 Million | $12.07 Million | 5.31x | 66.49x |
| 2016 | $1.07 Billion | $329.09 Million | $43.77 Million | 3.25x | 24.40x |
| 2017 | $1.24 Billion | $419.87 Million | $130.40 Million | 2.95x | 9.51x |
| 2018 | $856.23 Million | $660.22 Million | $307.41 Million | 1.30x | 2.79x |
| 2019 | $886.78 Million | $718.38 Million | $343.71 Million | 1.23x | 2.58x |
| 2020 | $1.13 Billion | $659.44 Million | $263.22 Million | 1.72x | 4.30x |
| 2021 | $1.03 Billion | $1.12 Billion | $483.77 Million | 0.92x | 2.13x |
| 2022 | $1.05 Billion | $1.42 Billion | $383.72 Million | 0.74x | 2.73x |
| 2023 | $869.75 Million | $1.09 Billion | $192.35 Million | 0.79x | 4.52x |
| 2024 | $1.09 Billion | $1.24 Billion | $309.21 Million | 0.87x | 3.51x |
Competitor Companies of 300401 by Market Capitalization
Companies near Zhejiang Garden Bio-chemical High-tech Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Zhejiang Garden Bio-chemical High-tech Co Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Zhejiang Garden Bio-chemical High-tech Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Zhejiang Garden Bio-chemical High-tech Co Ltd's market cap moved from $802.88 Million to $ 1.12 Billion, with a yearly change of 7.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.12 Billion | -0.33% |
| 2025 | CN¥1.12 Billion | +3.14% |
| 2024 | CN¥1.09 Billion | +24.85% |
| 2023 | CN¥869.75 Million | -16.99% |
| 2022 | CN¥1.05 Billion | +1.52% |
| 2021 | CN¥1.03 Billion | -8.87% |
| 2020 | CN¥1.13 Billion | +27.71% |
| 2019 | CN¥886.78 Million | +3.57% |
| 2018 | CN¥856.23 Million | -30.94% |
| 2017 | CN¥1.24 Billion | +16.07% |
| 2016 | CN¥1.07 Billion | +33.05% |
| 2015 | CN¥802.88 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Zhejiang Garden Bio-chemical High-tech Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.12 Billion USD |
| MoneyControl | $1.12 Billion USD |
| MarketWatch | $1.12 Billion USD |
| marketcap.company | $1.12 Billion USD |
| Reuters | $1.12 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.